Gurnell, MarkDomingo, ChristianRabe, Klaus FMenzies-Gow, AndrewPrice, DavidBrusselle, GuyWechsler, Michael EXia, ChangmingPandit-Abid, NamiGall, RebeccaJacob-Nara, Juby A.Rowe, Paul J.Deniz, YamoSiddiqui, Shahid2024-09-232024-09-232022-10-31Gurnell, M, Domingo, C, Rabe, K F, Menzies-Gow, A, Price, D, Brusselle, G, Wechsler, M E, Xia, C, Pandit-Abid, N, Gall, R, Jacob-Nara, J A, Rowe, P J, Deniz, Y & Siddiqui, S 2022, 'Dupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma', Chest, vol. 162, no. 4, Supplement, pp. A1909-A1913. https://doi.org/10.1016/j.chest.2022.08.15870012-3692RIS: urn:A9CB50D11FB0D572E9371C3A18934ABDhttps://hdl.handle.net/2164/24274Acknowledgments and funding sources Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02528214 (VENTURE)/NCT02134028 (TRAVERSE). Medical writing/editorial assistance was provided by Éilis Sutton, PhD, of Excerpta Medica, and was funded by Sanofi and Regeneron Pharmaceuticals, Inc., according to the Good Publication Practice guideline.135769engSDG 3 - Good Health and Well-beingR MedicineRJournal item10.1016/j.chest.2022.08.1587https://www.sciencedirect.com/science/article/pii/S00123692220294761624